[HTML][HTML] Protein acylation: mechanisms, biological functions and therapeutic targets

S Shang, J Liu, F Hua - Signal Transduction and Targeted Therapy, 2022 - nature.com
Metabolic reprogramming is involved in the pathogenesis of not only cancers but also
neurodegenerative diseases, cardiovascular diseases, and infectious diseases. With the …

Thiazole: A review on chemistry, synthesis and therapeutic importance of its derivatives

M T. Chhabria, S Patel, P Modi… - Current topics in …, 2016 - benthamdirect.com
Thiazole, a unique heterocycle containing sulphur and nitrogen atoms, occupies an
important place in medicinal chemistry. It is an essential core scaffold present in many …

[HTML][HTML] Association of body mass index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease: a Mendelian …

MM Mendelson, RE Marioni, R Joehanes, C Liu… - PLoS …, 2017 - journals.plos.org
Background The link between DNA methylation, obesity, and adiposity-related diseases in
the general population remains uncertain. Methods and Findings We conducted an …

Myocardial fatty acid metabolism in health and disease

GD Lopaschuk, JR Ussher, CDL Folmes… - Physiological …, 2010 - journals.physiology.org
There is a constant high demand for energy to sustain the continuous contractile activity of
the heart, which is met primarily by the β-oxidation of long-chain fatty acids. The control of …

[HTML][HTML] Targeting fatty acid and carbohydrate oxidation—a novel therapeutic intervention in the ischemic and failing heart

JS Jaswal, W Keung, W Wang, JR Ussher… - … et Biophysica Acta (BBA …, 2011 - Elsevier
Cardiac ischemia and its consequences including heart failure, which itself has emerged as
the leading cause of morbidity and mortality in developed countries are accompanied by …

Malonyl-CoA, a key signaling molecule in mammalian cells

D Saggerson - Annu. Rev. Nutr., 2008 - annualreviews.org
Malonyl-CoA can be formed within the mitochondria, peroxisomes, and cytosol of
mammalian cells. Besides being an intermediate in the pathways of de novo fatty acid …

Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway

Z Zhang, S Wang, S Zhou, X Yan, Y Wang… - Journal of Molecular and …, 2014 - Elsevier
Type 2 diabetes mellitus (T2DM)-induced cardiomyopathy is associated with cardiac
oxidative stress, inflammation, and remodeling. Sulforaphane (SFN), an isothiocyanate …

Endothelial cell–cardiomyocyte crosstalk in diabetic cardiomyopathy

A Wan, B Rodrigues - Cardiovascular research, 2016 - academic.oup.com
The incidence of diabetes is increasing globally, with cardiovascular disease accounting for
a substantial number of diabetes-related deaths. Although atherosclerotic vascular disease …

Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy

Z Chen, ZX Jin, J Cai, R Li, KQ Deng, YX Ji… - Journal of Molecular …, 2022 - Springer
Metabolic cardiomyopathy is an emerging cause of heart failure in patients with obesity,
insulin resistance, and diabetes. It is characterized by impaired myocardial metabolic …

[HTML][HTML] AMPK β1 deletion reduces appetite, preventing obesity and hepatic insulin resistance

N Dzamko, BJW van Denderen, AL Hevener… - Journal of Biological …, 2010 - ASBMB
The AMP-activated protein kinase (AMPK) is an αβγ heterotrimer that regulates appetite and
fuel metabolism. We have generated AMPK β1−/− mice on a C57Bl/6 background that are …